screening for breast cancer

... 0.75-0.99) for breast Breast Cancer Screening 13 Oregon Evidence-based Practice Center cancer mortality for women randomly assigned to mammography screening The number needed to invite for screening ... Relative Risk for Breast Cancer Mortality from Mammography Screening Trials for All Ages Age, y Trials Included, n* RR for Breast Cancer Mortality (95% CrI) NNI to Prevent Breast Cancer Death ... relative risk for breast cancer mortality of 0.85 (95% CrI, 0.75-0.96) for women randomly assigned to screening, and a number needed to invite for screening to prevent one breast cancer death...

Ngày tải lên: 14/02/2014, 21:20

... symptoms of breast cancer Treatment of these healthy women increases their risk of dying, e.g from heart disease and cancer It therefore no longer seems reasonable to attend for breast cancer screening ... that regular screening of 2000 women for 10 years is necessary to save one of them from dying of breast cancer The absolute reduction in breast cancer mortality was therefore only 0.05% Screening ... websites of possible benefits and harms from screening for breast cancer: cross sectional study BMJ 2004;328:148-51 Gøtzsche PC, Nielsen M Screening for breast cancer with mammography Cochrane Database...

Ngày tải lên: 15/02/2014, 05:20

... 23 Cancer detection programmes 24 Early detection of cancer 24 Cancer screening 24 Screening for breast cancer 26 Screening approach 26 Guidelines for ... detection and screening of breast cancer 51 Annex Consensus opinion of the regional task force for developing breast cancer prevention, screening and management guidelines 52 Foreword In ... of breast cancer 13 need for increased community awareness about breast cancer in the Region and the need for early detection International collaboration in breast cancer control In 2002, a Breast...

Ngày tải lên: 28/03/2014, 23:20

... investments to improve access, breast cancer screening has reached near-parity between African Americans and whites; Hispanics still lag behind [1-3] Breast cancer screening is not yet population-wide, ... be an effective implementation model for increasing evidence-based breast cancer screening recommendations among practices in urban areas of higher breast cancer mortality The sampling process ... implementation for the enhanced academic detailing intervention, that is, the presence or absence of tools, systems, or approaches that support breast cancer screening (e.g., computerized systems for tracking...

Ngày tải lên: 11/08/2014, 05:22

... investments to improve access, breast cancer screening has reached near-parity between African Americans and whites; Hispanics still lag behind [1-3] Breast cancer screening is not yet population-wide, ... be an effective implementation model for increasing evidence-based breast cancer screening recommendations among practices in urban areas of higher breast cancer mortality The sampling process ... implementation for the enhanced academic detailing intervention, that is, the presence or absence of tools, systems, or approaches that support breast cancer screening (e.g., computerized systems for tracking...

Ngày tải lên: 11/08/2014, 16:20

... care provider trained in screening for skin cancers The general population not at increased risk of skin cancer There is at this time no evidence for or against skin cancer screening of the general ... effects of screening for skin cancer As experts in the treatment and epidemiology of skin cancer, the guideline panel members were aware that some individuals are at increased risk for skin cancer ... recommended for individuals at average or low risk for skin cancer Key Evidence (Please see Section for the complete systematic review of the evidence conducted by the Skin Cancer Screening Guideline...

Ngày tải lên: 15/02/2014, 05:20

... cervical cancer The National Co-ordinating Network for Cervical Screening Working Group Br J Cancer 1996; 73(8):1001–1005 31 Morrison BJ Screening for Cervical Cancer In: Canadian Task Force on ... Evaluation of Cervical Cancer Screening Programmes Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies ... of Screening Tests Cervical cancer screening tests potentially appropriate for primary care settings include cervical cytology, conventional and new technologies, and tests for HPV infection Screening...

Ngày tải lên: 06/03/2014, 02:21

... of the 15 formulations is listed in the first four columns of Table S1 in Additional file Screening for polyester selection based on the blank particle mean diameter For the first screening test, ... nanocapsule form This observation was consistent with a previous report [48] related to a nanoparticulate form of another anticancer drug (doxorubicin) tested on a different breast cancer cell ... experiment was performed in triplicate Screening for stabilizer selection based on the blank particle mean diameter Since PVA could be used as an emulsion stabilizer in the NCs' formulation process,...

Ngày tải lên: 18/06/2014, 22:20

... commonly used in the treatment of breast cancer, oval cancer, small and nonsmall cell lung cancer, prostate cancer, etc Its commercial formulation TaxotereÒ is formulated in high concentration ... multidrug resistance in human breast cancer cells and therefore have considerable potential for treatment of breast cancer Acknowledgments The authors are grateful for financial support from the ... docetaxel formulation It can be found from Table that the IC50 value for MCF-7 TAX30 cells was decreased from 10.380, 8.726, and 5.945 lg/mL for TaxotereÒ to 7.388, 3.643, and 1.244 lg/mL for PCL NP formulation...

Ngày tải lên: 22/06/2014, 00:20

... Differentiation Figure A schematic summary of breast cancer heterogeneity According to the cancer stem cell hypothesis, breast cancer is driven by a limited number of cancer- initiating cells The progeny ... SNPs are differen tially expressed in the breast cancer subtypes Breast Cancer Res 2007, 9:113 Cleator S, Heller W, Coombes RC: Triple-negative breast cancer: therapeutic options Lancet Oncol ... enough for therapeutic selection but knowledge of both genotype and phenotype is required Furthermore, Chin et al [1] provide lists of copy number alterations and potential cancer genes in breast cancers...

Ngày tải lên: 06/08/2014, 18:21

... following breast cancer surgeries: seromas following breast cancer surgeries Breast J 2007, 13:588-92 Burak WE Jr, Goodman PS, Young DC, Farrar WB: Seroma formation following axillary dissection for breast ... Riedner CS, Nelson BK: Seroma formation following breast cancer surgery Breast J 2003, 5:385-8 Woodworth PA, McBoyle MF, Helmer SD, Beamer RL: Seroma formation after breast cancer surgery: incidence ... drainage for the axillary wound after lymphadenectomy for breast cancer Br J Surg 2006, 93:820-4 Page of 32 Gong Y, Xu J, Shao J, Cheng H, Wu X, Zhao D, Xiong B: Prevention of seroma formation...

Ngày tải lên: 09/08/2014, 02:20

... localized estrogen receptors in human breast cancer Cancer Res 1990, 5012:3545-3550 British Breast Group: Assessment of response to treatment in advanced breast cancer Lancet 1974, 2:38-39 Hayward ... between Estrogen Receptor and Growth Factor Receptor Pathways as a Cause for Endocrine Therapy Resistance in Breast Cancer Clinical Cancer Research 2005, 112:865s-870s Legault-Poisson S, Jolivet J, ... Dodwell DJ, Anderson H, Redford J: Response after withdrawal of tamoxifen and progestogens in advanced breast cancer Annals Of Oncology: Official Journal Of The European Society For Medical Oncology/...

Ngày tải lên: 09/08/2014, 02:21

... tamoxifen for prevention of breast cancer Br J Cancer 1989, 60(1):126-31 Fisher B, Costantino JP, Redmond CK, Fisher ER, Wickerham DL, Cronin WM: Endometrial cancer in tamoxifen-treated breast cancer ... 33(4):445-8 Early Breast Cancer Trialists’ Collaborative Group: Tamoxifen for early breast cancer: an overview of the randomized trials Lancet 1998, 351:1451-1467 Cuzick J, Powles T, Veronesi U, Forbes ... for Research on Cancer, Lyon, France 1996, 66:253-365 11 Swerdlow AJ, Jones ME: Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study J Natl Cancer Inst 2005,...

Ngày tải lên: 09/08/2014, 03:22

... hyperplastic lesions of the female breast A long-term follow-up study Cancer 1985, 55:2698-2708 Dupont WD, Page DL: Risk factors for breast cancer in women with proliferative breast disease New England ... Rosen PP: Proliferative breast "disease" An unresolved diagnostic dilemma Cancer 1993, 71:3798-3807 Shackney SE, Silverman JF: Molecular evolutionary patterns in breast cancer Advances in anatomic ... Conclusion Only age at the time of biopsy ( 50 years) is an independent predictive factor for breast cancer at surgical excision in patients with diagnosed ADH at CNB Identification of patients...

Ngày tải lên: 09/08/2014, 04:21

... to 10 Gy for early reactions, Gy for late reactions In the group assigned to receive 45 Gy to the whole breast, BED was 55 Gy for early effects, 78 Gy for late effects versus 60 Gy for early ... Collins R, Darby S, Early Breast Cancer Trialists’ Collaborative Group (EBCTCG): Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence ... S, Benk V, Szechtman B: Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer J Natl Cancer Inst 2002, 94(15):1143-50 Owen JR, Ashton...

Ngày tải lên: 09/08/2014, 09:20

... of model parameters for a dose-response relationship for breast cancer covering dose levels relevant for radiotherapy In addition a model for the age dependence of breast cancer risk was verified ... to a 30-fold increased risks for breast cancer compared with their peers in the general population Travis et al [8] for instance studied breast cancer induction for mantle field treatments of ... a dose-response relationship for breast cancer was derived based on the analysis of breast cancer induction after Hodgkin’s disease, a cancer risk model developed for high doses including fractionation...

Ngày tải lên: 09/08/2014, 09:20

... MCF-10A breast normal cell line was noted than in the 4T1 and MCF-7 breast cancer cell lines Nonetheless, the Magh-Rh (H cit) and Lip-Magh-Rh (H cit) treatments were more selective to breast cancer ... Coughlin SS, Ekwueme DU: Breast cancer as a global health concern Cancer Epidemiol 2009, 33:315-318 Kostova I: Platinum complexes as anticancer agents Recent Pat Anticancer Drug Discov 2006, ... effect differed between breast normal (MCF-10A) and breast carcinoma (4T1 and MCF-7) cell lines, being more pronounced in breast normal cells (Table and 2) Our data are, therefore, in agreement with...

Ngày tải lên: 11/08/2014, 00:23

... one-time screening for lung cancer (LC) in a high risk cohort Lung Cancer 2001, 32:227-236 Marshall D, Simpson KN, Earle CC, Chu C-W: Economic decision analysis model of screening for lung cancer ... estimates female life expectancy for screen-detected cancer at 18.5 years, compared with 16.7 for males For a women with lung cancer, the expected gain from screening is 7.0 LYs, compared with ... McMahon PM, Christiani DC: Computed tomography screening for lung cancer British Medical Journal 2007, 334:271 Black WC, Baron JA: CT screening for lung cancer: spiraling Into confusion? Journal of...

Ngày tải lên: 13/08/2014, 11:22